BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 16, 2012
View Archived Issues
Roche divulges new tyrosine-protein kinase JAK inhibitors
Read More
Novel aptamer oligonucleotides designed in Italy
Read More
Bayer Schering discovers novel vasopressin receptor ligands
Read More
New CYPXVII inhibitors synthesized at Novartis
Read More
Purdue Pharma patents new sodium channel antagonists
Read More
Recombinant heat shock protein reduces atherogenesis in preclinical tests
Read More
AstraZeneca launches once-daily antihypertensive in U.S.
Read More
Exelixis reports novel PI3K-delta inhibitors
Read More
Novel GlyT1 inhibitors developed in Japan
Read More
Merck & Co. presents novel PDK1 inhibitors
Read More
New melanin-concentrating hormone receptor antagonists identified
Read More
New candidate cancer therapies under development at AstraZeneca
Read More
New cancer immunotherapy targets ALK-1 and VEGF pathways
Read More
GSK AMPK activators are active in diabetes and obesity models
Read More
Antimitotic cancer therapy shows promise in vivo and in vitro
Read More
Korean FDA clears phase II trial of ViroMed pain medicine
Read More
Gliolan gets Australian orphan drug status
Read More
Phase I/II ProSavin trial meets primary endpoint
Read More
AbGenomics presents antibody conjugates with anticancer activity
Read More
Eisai launches new formulation of rufinamide in U.K.
Read More
Novel Astellas histone deacetylase inhibitor has encouraging pharmacokinetics
Read More
Quantum Genomics launches first clinical study of its lead antihypertensive drug
Read More
GW confirms milestone payment from Almirall
Read More
Biodel selects ultrarapid-acting insulin formulation to advance to phase II testing
Read More
Piramal Imaging acquires PET tracers from Bayer
Read More
